860
Participants
Start Date
November 22, 2022
Primary Completion Date
November 1, 2028
Study Completion Date
November 1, 2028
Data observation
At the time of participant inclusion in the study, demographic data and a baseline serum creatinine measurement will be collected. During the patient's ICU stay, the occurrence and duration of any AKI episode will be recorded. Data related to diagnostic examinations of these AKI episodes will also be collected in accordance with practices guidelines. Data related to AKI monitoring will also be collected, including serum creatinine and urea daily follow-up measurements, diuresis, and nephrotoxic use. The patient's need for extrarenal epuration or use of catecholamines will also be recorded. In the 3-month and 12-month.
RECRUITING
Centre Jean-Perrin, Clermont-Ferrand
RECRUITING
CHU clermont-ferrand, Clermont-Ferrand
University Hospital, Clermont-Ferrand
OTHER